In India, the drug for treating mucormicosis, also known as black fungal disease, has been released under the name ‘Posaforce 100’.
Mankind Pharma has announced the launch in India of Posaconazole resistant tablets to treat mucormicosis, also known as black fungi disease. “As the cases of black fungi are increasing day by day, the product was launched to fight against this infection. The drug signature always strives to launch affordable medications with an effort to achieve the best quality standards in the pharmaceutical industry “, Pharma de Mankind Pharma said in a statement on Thursday.
In India, the tablets have been released under the name “Posaforce 100”. The medication was also noted in its statement, the drug received the approval of the India General Drug Controller (DCGI), since several studies have found that it is a safer and more effective medication to treat mucormicosis. Both the Institute of Medical Sciences of India (AIIM) and the Indian Council of Medical Research (ICMR) have also recommended Posaconazole as an effective option to treat black fungi.
In addition, the antifungal medication has been erased for use in the United States also by drug and food administration (USFDA).
In India, cases of black fungi, which are commonly produced in the soil, have been detected in patients who have recovered from Coronavirus’s disease (COVID-19). As of June 10, more than 12,000 cases of mucormicosis have been detected in the country with States such as Gujarat, Maharashtra, Madhya Pradesh, Andhra Pradesh and Telangana representing the maximum number of such patients.